Oral and Conjunctival Exposure of Nonhuman Primates to Low Doses of Ebola Makona Virus

Chad Mire, Joan B. Geisbert, Krystle N. Agans, Daniel J. Deer, Karla A. Fenton, Thomas Geisbert

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Nonhuman primate (NHP) models of Ebola virus (EBOV) infection primarily use parenteral or aerosol routes of exposure. Uniform lethality can be achieved in these models at low doses of EBOV (≤100 plaque-forming units [PFU]). Here, we exposed NHPs to low doses of EBOV (Makona strain) by the oral or conjunctival routes. Surprisingly, animals exposed to 10 PFU by either route showed no signs of disease. Exposure to 100 PFU resulted in illness and/or lethal infection. These results suggest that these more natural routes require higher doses of EBOV to produce disease or that there may be differences between Makona and historical strains.

Original languageEnglish (US)
Pages (from-to)S263-S267
JournalJournal of Infectious Diseases
Volume214
DOIs
StatePublished - Oct 15 2016

Fingerprint

Ebolavirus
Primates
Ebola Hemorrhagic Fever
Aerosols
Infection

Keywords

  • Ebola virus
  • Nonhuman primate
  • Pathogenesis

ASJC Scopus subject areas

  • Immunology and Allergy
  • Infectious Diseases

Cite this

Oral and Conjunctival Exposure of Nonhuman Primates to Low Doses of Ebola Makona Virus. / Mire, Chad; Geisbert, Joan B.; Agans, Krystle N.; Deer, Daniel J.; Fenton, Karla A.; Geisbert, Thomas.

In: Journal of Infectious Diseases, Vol. 214, 15.10.2016, p. S263-S267.

Research output: Contribution to journalArticle

Mire, Chad ; Geisbert, Joan B. ; Agans, Krystle N. ; Deer, Daniel J. ; Fenton, Karla A. ; Geisbert, Thomas. / Oral and Conjunctival Exposure of Nonhuman Primates to Low Doses of Ebola Makona Virus. In: Journal of Infectious Diseases. 2016 ; Vol. 214. pp. S263-S267.
@article{23f11dc202dd4247ab480c78688bb338,
title = "Oral and Conjunctival Exposure of Nonhuman Primates to Low Doses of Ebola Makona Virus",
abstract = "Nonhuman primate (NHP) models of Ebola virus (EBOV) infection primarily use parenteral or aerosol routes of exposure. Uniform lethality can be achieved in these models at low doses of EBOV (≤100 plaque-forming units [PFU]). Here, we exposed NHPs to low doses of EBOV (Makona strain) by the oral or conjunctival routes. Surprisingly, animals exposed to 10 PFU by either route showed no signs of disease. Exposure to 100 PFU resulted in illness and/or lethal infection. These results suggest that these more natural routes require higher doses of EBOV to produce disease or that there may be differences between Makona and historical strains.",
keywords = "Ebola virus, Nonhuman primate, Pathogenesis",
author = "Chad Mire and Geisbert, {Joan B.} and Agans, {Krystle N.} and Deer, {Daniel J.} and Fenton, {Karla A.} and Thomas Geisbert",
year = "2016",
month = "10",
day = "15",
doi = "10.1093/infdis/jiw149",
language = "English (US)",
volume = "214",
pages = "S263--S267",
journal = "Journal of Infectious Diseases",
issn = "0022-1899",
publisher = "Oxford University Press",

}

TY - JOUR

T1 - Oral and Conjunctival Exposure of Nonhuman Primates to Low Doses of Ebola Makona Virus

AU - Mire, Chad

AU - Geisbert, Joan B.

AU - Agans, Krystle N.

AU - Deer, Daniel J.

AU - Fenton, Karla A.

AU - Geisbert, Thomas

PY - 2016/10/15

Y1 - 2016/10/15

N2 - Nonhuman primate (NHP) models of Ebola virus (EBOV) infection primarily use parenteral or aerosol routes of exposure. Uniform lethality can be achieved in these models at low doses of EBOV (≤100 plaque-forming units [PFU]). Here, we exposed NHPs to low doses of EBOV (Makona strain) by the oral or conjunctival routes. Surprisingly, animals exposed to 10 PFU by either route showed no signs of disease. Exposure to 100 PFU resulted in illness and/or lethal infection. These results suggest that these more natural routes require higher doses of EBOV to produce disease or that there may be differences between Makona and historical strains.

AB - Nonhuman primate (NHP) models of Ebola virus (EBOV) infection primarily use parenteral or aerosol routes of exposure. Uniform lethality can be achieved in these models at low doses of EBOV (≤100 plaque-forming units [PFU]). Here, we exposed NHPs to low doses of EBOV (Makona strain) by the oral or conjunctival routes. Surprisingly, animals exposed to 10 PFU by either route showed no signs of disease. Exposure to 100 PFU resulted in illness and/or lethal infection. These results suggest that these more natural routes require higher doses of EBOV to produce disease or that there may be differences between Makona and historical strains.

KW - Ebola virus

KW - Nonhuman primate

KW - Pathogenesis

UR - http://www.scopus.com/inward/record.url?scp=84990942794&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84990942794&partnerID=8YFLogxK

U2 - 10.1093/infdis/jiw149

DO - 10.1093/infdis/jiw149

M3 - Article

C2 - 27284090

AN - SCOPUS:84990942794

VL - 214

SP - S263-S267

JO - Journal of Infectious Diseases

JF - Journal of Infectious Diseases

SN - 0022-1899

ER -